NASDAQ$OMDA
Omada Health Inc · Q2 2025 earnings
Q2 2025 earnings ·
Briefing
OMDA Q2 2025 — $15.0M revenue, 0.24 EPS
There can be no assurance that actual results will not materially differ from expectations. Omada Health Inc reported Q2 2025 results. Diluted EPS came in at $0.24. Net income of $14.8M. Headline numbers extracted from the Form 10-Q press release; narrative is light because this row was processed without an LLM call.
- Revenue: $15.0M.
- Diluted EPS: $0.24.
- Net income: $14.8M.
- Operating income: $4K.
- Gross profit: $40K.
Headline financials
Revenue & EPS history
Omada Health Inc · Revenue · Quarterly
$61.4M
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 3 quarterly earnings reports · overlaid with Q2 2025
-3.9%
Avg return
Earnings day
+0.0%
Avg return
5 days after
-0.9%
Avg return
30 days after
25%
1 / 4 earnings
Positive
+3.3%
Q4 2025
Best reaction
-9.6%
Q1 2026
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -9.6% | -2.3% | — | |
| Q4 2025 | +3.3% | +1.0% | -7.5% | |
| Q3 2025 | -7.1% | -1.9% | -20.0% | |
| Q2 2025 | -2.3% | +3.2% | +24.8% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro